Barclays PLC cut its holdings in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 69.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 121,251 shares of the company's stock after selling 272,474 shares during the period. Barclays PLC owned 0.07% of BrightSpring Health Services worth $2,066,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Virtu Financial LLC purchased a new position in BrightSpring Health Services in the 3rd quarter worth $522,000. JPMorgan Chase & Co. raised its stake in shares of BrightSpring Health Services by 275.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 163,618 shares of the company's stock valued at $2,402,000 after buying an additional 120,005 shares during the last quarter. SG Americas Securities LLC lifted its holdings in shares of BrightSpring Health Services by 50.9% in the 4th quarter. SG Americas Securities LLC now owns 37,000 shares of the company's stock valued at $630,000 after buying an additional 12,486 shares during the period. R Squared Ltd purchased a new stake in shares of BrightSpring Health Services in the fourth quarter worth about $74,000. Finally, Legato Capital Management LLC grew its holdings in BrightSpring Health Services by 40.0% during the fourth quarter. Legato Capital Management LLC now owns 66,910 shares of the company's stock worth $1,139,000 after acquiring an additional 19,120 shares during the period.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the stock. Mizuho set a $26.00 target price on shares of BrightSpring Health Services in a report on Monday. UBS Group increased their price target on BrightSpring Health Services from $22.00 to $30.00 and gave the stock a "buy" rating in a research report on Wednesday, January 29th. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, BrightSpring Health Services currently has a consensus rating of "Moderate Buy" and an average price target of $22.33.
View Our Latest Analysis on BTSG
BrightSpring Health Services Price Performance
Shares of BrightSpring Health Services stock traded up $1.21 during trading hours on Wednesday, reaching $23.04. 3,934,473 shares of the company's stock were exchanged, compared to its average volume of 1,352,796. The company has a quick ratio of 0.97, a current ratio of 1.35 and a debt-to-equity ratio of 1.63. The business has a fifty day moving average of $17.79 and a two-hundred day moving average of $18.61. BrightSpring Health Services, Inc. has a 1 year low of $10.15 and a 1 year high of $24.82. The company has a market capitalization of $4.03 billion, a P/E ratio of -88.62 and a beta of 2.06.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last posted its earnings results on Friday, May 2nd. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.10. The company had revenue of $2.88 billion for the quarter, compared to analyst estimates of $2.74 billion. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. BrightSpring Health Services's revenue was up 25.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.12 EPS. As a group, research analysts predict that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.
About BrightSpring Health Services
(
Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Further Reading
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
